Fuda Cancer Hospital, Guangzhou: Pancreatic Neoplasms trials
The registry lists 12 Pancreatic Neoplasms studies with Fuda Cancer Hospital, Guangzhou as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 1 6Phase 2 8Phase 3 1No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic CancerWithdrawnNCT03509298Phase 2
- PENS or TENS for Pain in Pancreatic CancerCompletedNCT03331055Not applicable
- Bioinformation Therapy for Pancreatic CancerCompletedNCT03239184Phase 2/3
- Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic CancerCompletedNCT03180437Phase 1/2
- High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic CancerCompletedNCT03008304Phase 1/2
- Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic CancerCompletedNCT02981719Not applicable
- Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic CancerCompletedNCT02718859Phase 1/2
- HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic CancerWithdrawnNCT02449967Phase 1/2
- Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic CarcinomaNo longer availableNCT02449135
- Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic CancerCompletedNCT02343835Not applicable
- Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma PatientCompletedNCT02338752Phase 1/2
- Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic CancerCompletedNCT02074046Phase 1/2